ASX:ACL

Australian Clinical Labs (ACL) Stock Price, News & Analysis

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
3.72%
Price Target
N/A
ACL stock logo

About Australian Clinical Labs Stock (ASX:ACL)

Australian Clinical Labs Limited provides pathology services in Australia. The company offers range of services, which include routine pathology test, advanced molecular genetics testing, harmony NIPT and first trimester screening, genetic carrier screening, chemical pathology, histopathology, and cytopathology; hematology, allergy, and immunology; serology and microbiology; and infectious molecular testing, cardiac testing services, functional pathology, veterinary pathology, and commercial drug and alcohol testing services. It offers its service to private and public hospitals. Australian Clinical Labs Limited was incorporated in 2020 and is headquartered in Clayton, Australia.

ACL Stock News Headlines

Australian Clinical Labs Ltd
Exposed: 10 CENT Crypto to Explode April 20th?
The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…
Exposed: 10 CENT Crypto to Explode April 20th?
The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…
See More Headlines
Receive ACL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Australian Clinical Labs and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 4/25 Dividend
3/27/2024
Today
4/24/2024
Dividend Payable
4/25/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Diagnostics & Research
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
5,115
Year Founded
N/A

Profitability

Net Income
$15.43 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$674.03 million
Book Value
A$0.82 per share

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
1.14
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Key Executives

  • Ms. Melinda McGrath
    CEO & Executive Director
  • Mr. James Davison
    Chief Financial Officer
  • Mr. Anthony Friedli
    Chief Operating Officer
  • Mr. Sean Jackson
    Chief Information Officer
  • Mr. Joe Geran
    National Marketing Director
  • Associate Prof. Tony Landgren
    National Medical Director & Chief Pathologist
  • Mr. Chris Brownlow
    Chief Executive Officer of New South Wales & Australian Capital Territory
  • Ms. Shae Seymour
    Chief Executive Officer of Western Australia
  • Mr. Eric Swayn
    Chief Executive Officer of South Australia & Northern Territory
  • Ms. Eleanor Padman B.A.
    FCIS, Company Secretary

ACL Stock Analysis - Frequently Asked Questions

How often does Australian Clinical Labs pay dividends? What is the dividend yield for Australian Clinical Labs?

Australian Clinical Labs announced a Interim dividend on Wednesday, March 27th. Shareholders of record on Thursday, April 25th will be paid a dividend of 0.03 per share on Thursday, April 25th. This represents a yield of 1.1%. The ex-dividend date of this dividend is Wednesday, March 27th.
Read our dividend analysis for ACL
.

Is Australian Clinical Labs a good dividend stock?

Australian Clinical Labs (ASX:ACL) pays an annual dividend of A$0.10 per share and currently has a dividend yield of 3.72%. The dividend payout ratio is 125.00%. Payout ratios above 75% are not desirable because they may not be sustainable.
Read our dividend analysis for ACL.

This page (ASX:ACL) was last updated on 4/24/2024 by MarketBeat.com Staff

From Our Partners